INSYS Therapeutics (INSY) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free INSY Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis INSYS Therapeutics Short Interest DataCurrent Short Volume10,386,000 sharesPrevious Short Volume11,347,100 sharesChange Vs. Previous Month-8.47%Dollar Volume Sold Short$8.10 millionShort Interest Ratio / Days to Cover5.9Last Record DateMay 31, 2019Outstanding Shares74,570,000 sharesFloat Size26,880,000 sharesShort Percent of Float38.64%Today's Trading Volume0 sharesAverage Trading Volume9,520,592 sharesToday's Volume Vs. Average0% Short Selling INSYS Therapeutics ? Sign up to receive the latest short interest report for INSYS Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINSY Short Interest Over TimeINSY Days to Cover Over TimeINSY Percentage of Float Shorted Over Time Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... INSYS Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/201910,386,000 shares $8.10 million -8.5%38.6%5.9 $0.78 5/15/201911,347,100 shares $13.28 million -4.8%42.3%9.9 $1.17 INSY Short Interest - Frequently Asked Questions What is INSYS Therapeutics' current short interest? Short interest is the volume of INSYS Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 31st, investors have sold 10,386,000 shares of INSY short. 38.64% of INSYS Therapeutics' shares are currently sold short. Learn More on INSYS Therapeutics' current short interest. What is a good short interest ratio for INSYS Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INSY shares currently have a short interest ratio of 6.0. Learn More on INSYS Therapeutics's short interest ratio. What is a good short interest percentage for INSYS Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 38.64% of INSYS Therapeutics' floating shares are currently sold short. Is INSYS Therapeutics' short interest increasing or decreasing? INSYS Therapeutics saw a decline in short interest in the month of May. As of May 31st, there was short interest totaling 10,386,000 shares, a decline of 8.5% from the previous total of 11,347,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is INSYS Therapeutics' float size? INSYS Therapeutics currently has issued a total of 74,570,000 shares. Some of INSYS Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. INSYS Therapeutics currently has a public float of 26,880,000 shares. How does INSYS Therapeutics' short interest compare to its competitors? 38.64% of INSYS Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to INSYS Therapeutics: TherapeuticsMD, Inc. (0.41%), Flora Growth Corp. (7.33%), Benitec Biopharma Inc. (0.50%), RenovoRx, Inc. (0.45%), Oncternal Therapeutics, Inc. (0.52%), Onconova Therapeutics, Inc. (0.12%), Synlogic, Inc. (0.53%), Lisata Therapeutics, Inc. (0.24%), Cumberland Pharmaceuticals Inc. (0.22%), CytoMed Therapeutics Limited (0.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: American Airlines Group Inc. ($737.95 million), AAON, Inc. ($206.74 million), Luxoft Holding Inc ($119.37 million), KEYW Holding Corp. ($85.94 million), Applied Optoelectronics, Inc. ($76.08 million), Quantenna Communications Inc ($40.16 million), INSYS Therapeutics, Inc. ($8.10 million), Ares Acquisition Co. ($4.03 million), and FTD Companies, Inc. ($2.51 million). View all of the most shorted stocks. What does it mean to sell short INSYS Therapeutics stock? Short selling INSY is an investing strategy that aims to generate trading profit from INSYS Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against INSYS Therapeutics? A short squeeze for INSYS Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INSY, which in turn drives the price of the stock up even further. How often is INSYS Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INSY, twice per month. The most recent reporting period available is May, 31 2019. More Short Interest Resources from MarketBeat Related Companies: TXMD Short Interest Data FLGC Short Interest Data BNTC Short Interest Data RNXT Short Interest Data ONCT Short Interest Data ONTX Short Interest Data SYBX Short Interest Data LSTA Short Interest Data CPIX Short Interest Data GDTC Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INSY) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmith